Pharming Group Company Description
Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3Kẟ inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome.
It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE.
The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105.
Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
![Pharming Group logo](https://img.stockanalysis.com/logos1/AS/PHARM.png)
Country | Netherlands |
Founded | 1988 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 382 |
CEO | Sijmen de Vries |
Contact Details
Address: Darwinweg 24 Leiden, 2333 CR Netherlands | |
Phone | 31 71 524 7400 |
Website | pharming.com |
Stock Details
Ticker Symbol | PHARM |
Exchange | Euronext Amsterdam |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | NL0010391025 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. Sijmen de Vries M.B.A., M.D. | President, Chief Executive Officer and Executive Director |
Jeroen Wakkerman | Chief Financial Officer |
Mireille Sanders M.Sc. | Chief Operations Officer |
Susanne Embleton | Investor Relations Manager |
Ruud Van Outersterp | Chief Ethics and Compliance Officer |
Dr. Anurag Relan M.D., MPH | Chief Medical Officer |
Stephen Toor | Chief Commercial Officer and GM Americas |
Dr. Alexander Breidenbach M.B.A. | Chief Business Officer |
Dr. Bruno M. L. Giannetti | Consultant |